Viewing Study NCT05345158


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-01-22 @ 1:59 PM
Study NCT ID: NCT05345158
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2022-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
Sponsor: University Health Network, Toronto
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphadenopathy Retroperitoneal View
None Stage II Testicular Seminoma View
Keywords: